You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MM-Multiple Myeloma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

Recruiting
  • Multiple Myeloma
  • Autologous hematopoietic stem cell transplantation
  • C-CAR088
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 21, 2022

Learn About Medicine in People With Relapsed Refractory Multiple

Completed
  • Multiple Myeloma
  • New York, New York
    Pfizer
Nov 14, 2022

Multiple Myeloma, Osteoporosis Trial in United States (Romosozumab)

Recruiting
  • Multiple Myeloma
  • Osteoporosis
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2023

Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

Recruiting
  • Multiple Myeloma
  • anti-BCMA/GPRC5D CAR-T CELL
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 19, 2022

Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Relapsed Refractory Multiple Myeloma
  • (no location specified)
Feb 6, 2023

Living With Multiple Myeloma (PaCE-MM)

Recruiting
  • Multiple Myeloma
  • Comprehensive Geriatric Assessment
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Mar 11, 2022

Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial (3x10(6) CART-38 cellls, 7x10(5) CART-38 cells, 7x10(6) CART-38 cells)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Multiple Myeloma (MM)
  • 3x10(6) CART-38 cellls
  • +5 more
  • (no location specified)
Jul 15, 2022

Multiple Myeloma Trial in Tianjin (Anlotinib Hydrochloride Capsule)

Recruiting
  • Multiple Myeloma
  • Anlotinib Hydrochloride Capsule
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 18, 2022

Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 30, 2022

Multiple Myeloma Trial in Beijing (melphalan HCl for injection)

Recruiting
  • Multiple Myeloma
  • melphalan hydrochloride for injection
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 26, 2022

Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 13, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Mar 24, 2022

Multiple Myeloma, Lymphoma Trial in China (Etoposide, Cyclophosphamide, Mecapegfilgrastim, day 2)

Recruiting
  • Multiple Myeloma
  • Lymphoma
  • Hefei, Anhui, China
  • +6 more
Dec 1, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Mar 24, 2022

Multiple Myeloma Trial in Shanghai, Wenzhou (Human BCMA Targeted T Cells Injection)

Recruiting
  • Multiple Myeloma
  • Human BCMA Targeted T Cells Injection
  • Shanghai, Shanghai, China
  • +1 more
Dec 7, 2022

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in United States (REGN5459)

Active, not recruiting
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Indianapolis, Indiana
  • +6 more
Aug 16, 2022

Multiple Myeloma Trial (REGN5458)

Available
  • Multiple Myeloma
  • (no location specified)
Dec 9, 2021

Multiple Myeloma (MM) Trial in Japan (OPC-415)

Recruiting
  • Multiple Myeloma (MM)
  • OPC-415
  • Isehara-shi, Japan
  • +4 more
Apr 20, 2022

Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

Recruiting
  • Multiple Myeloma (MM)
  • +5 more
  • Santander, Cantabria, Spain
  • +4 more
Jun 19, 2023

Multiple Myeloma Trial in Torino (Pomalidomide, Cyclophosphamide, Prednisone)

Active, not recruiting
  • Multiple Myeloma
  • Pomalidomide, Cyclophosphamide, Prednisone
  • Torino, Italy
    AOU Città della Salute e della Scienza di Torino - SC Ematologia
Mar 24, 2022

Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)

Recruiting
  • Multiple Myeloma
  • Torino, TO, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

Recruiting
  • Elranatamab
  • +10 more
  • Fuzhou, Fujian, China
  • +18 more
Jan 18, 2023